Free Trial

Alto Neuroscience (ANRO) News Today

Alto Neuroscience logo
$2.16 -0.11 (-4.63%)
As of 10:20 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Analysts Set Expectations for ANRO Q1 Earnings
Alto Neuroscience, Inc. stock logo
What is Wedbush's Estimate for ANRO FY2029 Earnings?
Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Stock analysts at Wedbush issued their FY2029 earnings per share estimates for Alto Neuroscience in a research report issued on Thursday, March 20th. Wedbush analyst L. Chico anticipates that the company will post earnings per share of ($2.88) f
Alto Neuroscience, Inc. stock logo
What is William Blair's Forecast for ANRO Q1 Earnings?
Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Analysts at William Blair issued their Q1 2026 EPS estimates for Alto Neuroscience in a report released on Friday, March 21st. William Blair analyst M. Minter expects that the company will post earnings of ($0.53) per share for the quarter. Will
Brokerages Set Alto Neuroscience, Inc. (NYSE:ANRO) PT at $16.75
Alto Neuroscience, Inc. (ANRO) Gets a Hold from Wedbush
Alto Neuroscience, Inc. stock logo
Alto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by Analysts
Shares of Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) have been given an average rating of "Moderate Buy" by the six brokerages that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and three have issued a buy
Alto Neuroscience, Inc. stock logo
Alto Neuroscience's (ANRO) Outperform Rating Reaffirmed at William Blair
William Blair restated an "outperform" rating on shares of Alto Neuroscience in a research note on Friday.
Alto Neuroscience, Inc. stock logo
Alto Neuroscience (NYSE:ANRO) Posts Earnings Results, Beats Expectations By $0.09 EPS
Alto Neuroscience (NYSE:ANRO - Get Free Report) announced its quarterly earnings data on Thursday. The company reported ($0.56) earnings per share for the quarter, beating analysts' consensus estimates of ($0.65) by $0.09.
Alto Neuroscience, Inc. stock logo
Alto Neuroscience (ANRO) Expected to Announce Quarterly Earnings on Thursday
Alto Neuroscience (NYSE:ANRO) will be releasing earnings before the market opens on Thursday, March 20, Financial Modeling Prep reports.
Alto Neuroscience, Inc. stock logo
Alto Neuroscience (NYSE:ANRO) Trading Up 8.8% - Should You Buy?
Alto Neuroscience (NYSE:ANRO) Stock Price Up 8.8% - What's Next?
Alto Neuroscience rises 25.0%
Alto Neuroscience rises 19.6%
USPTO grants Alto Neuroscience patent for MDD treatment covering ALTO-300
TD Cowen Remains a Buy on Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience announces interim analysis from ALTO-300 trial
Alto Neuroscience files $300M mixed securities shelf
Alto Neuroscience, Inc. stock logo
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Consensus Rating of "Moderate Buy" from Analysts
Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) has received an average rating of "Moderate Buy" from the eight ratings firms that are currently covering the company, MarketBeat reports. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating
Alto Neuroscience, Inc. stock logo
Alto Neuroscience, Inc. (NYSE:ANRO) Given Average Rating of "Moderate Buy" by Brokerages
Shares of Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) have earned an average rating of "Moderate Buy" from the eight research firms that are currently covering the company, Marketbeat Ratings reports. Three investment analysts have rated the stock with a hold rating and five have issued
Alto Neuroscience, Inc. stock logo
Alto Neuroscience, Inc. (NYSE:ANRO) Stock Holdings Increased by Geode Capital Management LLC
Geode Capital Management LLC grew its position in shares of Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 148.7% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 469,988 shares of the company's stoc
Alto Neuroscience, Inc. stock logo
Alto Neuroscience, Inc. (NYSE:ANRO) Shares Purchased by State Street Corp
State Street Corp raised its holdings in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 123.7% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 236,857 shares of the company's stock af
Alto Neuroscience, Inc. stock logo
Franklin Resources Inc. Purchases 595,673 Shares of Alto Neuroscience, Inc. (NYSE:ANRO)
Franklin Resources Inc. increased its position in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 95.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,220,712 shares of the company's stock after
Alto Neuroscience, Inc. (ANRO) Receives a Buy from JonesTrading
Alto Neuroscience, Inc. stock logo
Alto Neuroscience, Inc. (NYSE:ANRO) Short Interest Update
Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) was the target of a large decrease in short interest in the month of November. As of November 30th, there was short interest totalling 4,080,000 shares, a decrease of 12.4% from the November 15th total of 4,660,000 shares. Based on an average daily volume of 777,200 shares, the days-to-cover ratio is currently 5.2 days. Currently, 18.6% of the shares of the stock are sold short.
Alto Neuroscience, Inc. stock logo
Alto Neuroscience, Inc. (NYSE:ANRO) Receives Average Rating of "Moderate Buy" from Brokerages
Shares of Alto Neuroscience, Inc. (NYSE:ANRO - Get Free Report) have earned an average rating of "Moderate Buy" from the eight ratings firms that are currently covering the firm, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and five have assigned a buy rating to
Alto Neuroscience, Inc. stock logo
Jennison Associates LLC Acquires 370,612 Shares of Alto Neuroscience, Inc. (NYSE:ANRO)
Jennison Associates LLC lifted its stake in Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) by 80.3% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 832,290 shares of the company's stock after acquiring an additi
Alto Neuroscience, Inc. stock logo
FY2024 EPS Estimate for Alto Neuroscience Boosted by Analyst
Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Stock analysts at William Blair increased their FY2024 EPS estimates for Alto Neuroscience in a note issued to investors on Wednesday, November 13th. William Blair analyst M. Minter now forecasts that the company will post earnings per share of
Alto Neuroscience, Inc. stock logo
FY2024 EPS Estimates for Alto Neuroscience Cut by Wedbush
Alto Neuroscience, Inc. (NYSE:ANRO - Free Report) - Research analysts at Wedbush decreased their FY2024 EPS estimates for shares of Alto Neuroscience in a research note issued on Wednesday, November 13th. Wedbush analyst L. Chico now expects that the company will post earnings per share of ($2.60
Alto Neuroscience price target lowered to $10 from $32 at Stifel
Alto Neuroscience, Inc. (ANRO) Receives a Buy from TD Cowen
Alto Neuroscience, Inc. stock logo
Stifel Nicolaus Issues Pessimistic Forecast for Alto Neuroscience (NYSE:ANRO) Stock Price
Stifel Nicolaus reduced their target price on shares of Alto Neuroscience from $32.00 to $10.00 and set a "buy" rating for the company in a report on Wednesday.
Remove Ads
Get Alto Neuroscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter.

ANRO Media Mentions By Week

ANRO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ANRO
News Sentiment

0.90

0.82

Average
Medical
News Sentiment

ANRO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ANRO Articles
This Week

7

2

ANRO Articles
Average Week

Remove Ads
Get Alto Neuroscience News Delivered to You Automatically

Sign up to receive the latest news and ratings for ANRO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NYSE:ANRO) was last updated on 3/31/2025 by MarketBeat.com Staff
From Our Partners